Buscar
Mostrando ítems 51-60 de 503
Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension Efectos hemodinámicos y funcionales hepáticos del 5-mononitrato de isosorbide en cirróticos con hipertensión portal.
(1993)
Isosorbide 5-mononitrate reduces portal pressure in acute conditions. The aim of this work was to assess its effects and tolerance development after 30 days of use in alcoholic cirrhotic patients without history of variceal ...
Síndrome hepatorrenal como consequência da hepatite lobular dissecante em dois cães
(Universidade Federal de Santa MariaBrasilUFSMCentro de Ciências Rurais, 2014-04-24)
The lobular dissecting hepatitis is characterized by the occurrence of hepatic and nodular fibrosis withacquired portosystemic shunts. It commonly occurs in young dogs with chronic hepatitis whose evolution is fast and the ...
Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension
(WILEY-BLACKWELL PUBLISHING, INC, 2009)
Background and Aim: Although prophylaxis with beta-blockers has been shown to decrease variceal pressure and wall tension in cirrhotic patients, this has not been demonstrated in non-cirrhotic portal hypertension caused ...
Kallikrein-kinin system in hepatic experimental models
(Elsevier B.V., 2005-08-01)
The purpose of this brief review is to describe some characteristics of the kallikrein-kinin system (KKS) in the liver. the liver synthesizes kininogens and prekallikrein and the synthesis of both proteins is increased in ...
Hepatic Veins and Inferior Vena Cava Thrombosis in a Child Treated by Transjugular Intrahepatic Portosystemic Shunt
(SPRINGER, 2010)
We report the case of a 9-year-old boy with portal hypertension, due to Budd-Chiari syndrome, and retrohepatic inferior vena cava thrombosis, submitted to a transjugular intrahepatic portosystemic shunt (TIPS) by connecting ...
Wandering spleen as a cause of sinistral portal hypertension
(HCPA/FAMED/UFRGS, 2021)
Long-term follow-up of children with extrahepatic portal vein obstruction: impact of an endoscopic sclerotherapy program on bleeding episodes, hepatic function, hypersplenism, and mortality
(W B SAUNDERS CO-ELSEVIER INC, 2009)
Background: Endoscopic sclerotherapy (ES) has been the standard treatment for children with idiopathic extrahepatic portal vein obstruction (EHPVO). Portosystemic shunts are indicated when variceal bleeding cannot be ...